2Teichholz LE, Kreulen T, Herman MV, et al. Problem in echocardiographic volume determinations: echocardiographic - angiographic correlations in the presence or absence of asynergy. Am J Cardiol, 1976,37 (1):7 ～11.
3[2]Herlitz J, Malmberg. K. How to improve the cardiac prognosis for diabtes. Diabtes Care, 1999,22 (supplz):89 ～ 96
4[6]Semen Kovich CF, Heinfche JW. Perspective in diabetes:the mystery Of diabetes and atherosclerosis. Diabetes,1997,16(3) :327
5Bax JJ.Assessment of myocardial viability:guide to prognosis and clinical management.Eur Heart J,2000,21:961-963.
6Allman KC,Shaw LJ,Hachamovitch R,et al.Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction:a meta-analysis.J Am Coll Cardiol,2002,39:1151-1158.
7Fitzgerald J,Parker JA,Danias PG.F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.J Nucl Cardiol,2000,7:382-387.
8Bax JJ,Wijns W,Cornel JH,et al.Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease:comparison of pooled data.J Am Col
9Tawakal A,Gewirtz H.Does CABG improve left ventricular ejection fraction in patients with ischemic cardiomyopathy,and Does it matter? J Nucl Med,2001,42(1):87-90.
10Schinkel AFL,Bax JJ,Sozzi FB,et al.Prevalence of myocardial viability assessed by single phone emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.Heart,2002,88:125-130.
